Our study revealed that in patients with β-TM, an increment in FOXO1 and HSP72 signaling with low levels of SIRT1 is linked to accelerated atherosclerosis, which is crucial as a novel biomarker for the prediction of atherosclerosis. The gene discussed is FOXO1; the disease is atherosclerosis.